Product Images Atropine Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Atropine Sulfate NDC 51662-1311 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

SERIALIZED POUCH LABEL - 51662131121 Atropine POUCH label

SERIALIZED POUCH LABEL - 51662131121 Atropine POUCH label

Atropine Sulfate Injection, USP is a medication provided in a 20mL vial, containing 8mg/20mL (0.4mg/mL) of the active ingredient. The medication is intended for intramuscular, intravenous, or subcutaneous use, and the usual dosage can be found in the package insert. The medication is supposed to be stored in a controlled room temperature range of 20-25°C (68-77°F). This medication is authorized for prescription use only and has an NDC number of 51662-13511-2. The medication is manufactured by HF Acquisition Co., LLC, located in Mukilteo, WA 98275.*

case - 51662131138 Atropine CASE label

case - 51662131138 Atropine CASE label

ATROPINE SULFATE INJECTION is an 8mg/20mL (0.4mg/mL) drug that comes in a 20mL vial, and is boxed in 25s. The package insert contains more information about dosage and administration. The drug should be stored at a controlled room temperature between 20-25°C (68-77°F). The product is manufactured by HF Acquisition Co., LLC in Mukilteo, Washington. The NDC for both the product and manufacturer is available, and the product is available only by prescription. Lot 12345 with an expiration date of 2030-06-30.*

Serialized RFID - 51662131138 Atropine RFID label

Serialized RFID - 51662131138 Atropine RFID label

ADVERSE EVENT TABEL - ADVERSE EVENT

ADVERSE EVENT TABEL - ADVERSE EVENT

This text appears to describe the range of effects that can occur when taking doses of a medication in milligrams, starting from 0.5mg and increasing up to a potentially fatal dose of 65mg. The text notes that at lower doses, one may experience slight dryness of the nose and mouth, as well as bradycardia (slowing of the heart). However, at higher doses, symptoms can escalate to include dry mouth, tachycardia (acceleration of the heart), mydriasis (dilation of the pupils), blurring of vision, difficulty speaking or swallowing, headache, and restlessness, among others. At extremely high doses, the medication can cause ataxia (loss of muscle control), excitement, disorientation, hallucinations, delirium, and even coma.*

DOSAGE - DOSAGE

DOSAGE - DOSAGE

This appears to be a chart showing the quantity of Atropine Sulfate Solution (in milliliters) required based on the desired dosage in milligrams per milliliter. It provides various dosage options ranging from 0.1mg/mL to 1mg/mL.*

LOGO - LOGO

LOGO - LOGO

SERIALIZED VIAL - SERIALIZED 51662 1311 1 Atropine 20mL Vial

SERIALIZED VIAL - SERIALIZED 51662 1311 1 Atropine 20mL Vial

STRUCTURE - STRUCTURE

STRUCTURE - STRUCTURE

VIAL - VIAL LABEL

VIAL - VIAL LABEL

This seems to be a label of a medication called "Atropine Sulfate Injection" with a concentration of 8mg/20mL. It is available in a multiple dose vial for IM, IV or SC use. No further information is provided.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.